{"title":"Engineering mitochondrial DNA deletions in human cells improves disease modeling","authors":"Iris Marchal","doi":"10.1038/s41587-025-02652-6","DOIUrl":"https://doi.org/10.1038/s41587-025-02652-6","url":null,"abstract":"<p>Genetically modifying human mitochondrial DNA (mtDNA) is challenging when generating large-scale deletions — a common cause of mitochondrial diseases — owing to the absence of double strand break repair machinery in mitochondria. Writing in <i>Cell</i>, Fu et al. describe a method to modulate large mtDNA deletions in human cells by co-expressing end-joining machinery from <i>Mycobacterium</i> or T4 bacteriophage with targeted endonucleases, providing insights into the underlying mechanisms of mitochondrial disease.</p><p>The presence of both normal and mutated mtDNA within cells, known as heteroplasmy, is decisive in mitochondrial disease as the proportion of mutated mtDNA dictates the severity of disease manifestation. To model mtDNA deletions at defined heteroplasmy levels, the authors co-expressed end-joining machinery with the restriction enzyme Scal in epithelial cells, resulting in a panel of cells with mtDNA deletions of around 3.5 kilobases. In-depth characterization of these cells revealed a critical threshold of about 75% heteroplasmy, beyond which cells showed impaired oxidative phosphorylation and reduced cell growth with a loss of TCA cycle metabolites and aspartate levels. Single-cell sequencing detected two nuclear gene expression programs that were deregulated with increased heteroplasmy, revealing a threshold-triggered response and a gradual heteroplasmy-sensing network. The functional relevance of such gene network disruptions should be studied further.</p>","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"6 1","pages":""},"PeriodicalIF":46.9,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143831821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mubin Tarannum, Xizhong Ding, Marta Barisa, Sabrina Hu, John Anderson, Rizwan Romee, Jin Zhang
{"title":"Engineering innate immune cells for cancer immunotherapy","authors":"Mubin Tarannum, Xizhong Ding, Marta Barisa, Sabrina Hu, John Anderson, Rizwan Romee, Jin Zhang","doi":"10.1038/s41587-025-02629-5","DOIUrl":"https://doi.org/10.1038/s41587-025-02629-5","url":null,"abstract":"<p>Innate immune cells, including natural killer cells, macrophages and γδ T cells, are gaining prominence as promising candidates for cancer immunotherapy. Unlike conventional T cells, these cells possess attributes such as inherent antitumor activity, rapid immune responses, favorable safety profiles and the ability to target diverse malignancies without requiring prior antigen sensitization. In this Review, we examine the engineering strategies used to enhance their anticancer potential. We discuss challenges associated with each cell type and summarize insights from preclinical and clinical work. We propose strategies to address existing barriers, providing a perspective on the advancement of innate immune engineering as a powerful modality in anticancer treatment.</p>","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"30 1","pages":""},"PeriodicalIF":46.9,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143831836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Virtual cells for predictive immunotherapy","authors":"Daniel R. Bergman, Elana J. Fertig","doi":"10.1038/s41587-025-02583-2","DOIUrl":"https://doi.org/10.1038/s41587-025-02583-2","url":null,"abstract":"Synergizing advances in artificial intelligence with mathematical modeling will improve our ability to computationally predict immunotherapy outcomes.","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"2020 1","pages":""},"PeriodicalIF":46.9,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143831852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Mismatch repair inhibitors lift off in Huntington’s","authors":"","doi":"10.1038/s41587-025-02646-4","DOIUrl":"https://doi.org/10.1038/s41587-025-02646-4","url":null,"abstract":"Startups targeting DNA repair seek to build on recent findings that neurodegeneration in Huntington’s disease is triggered only after CAG triplet repeats reach a critical threshold.","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"122 1","pages":""},"PeriodicalIF":46.9,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143831834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Putting cancer immunotherapy into spatial context in the clinic","authors":"Camilla Engblom, Joakim Lundeberg","doi":"10.1038/s41587-025-02596-x","DOIUrl":"https://doi.org/10.1038/s41587-025-02596-x","url":null,"abstract":"Spatial omics technologies offer insights into the organization of cellular and molecular components and their interactions within the tumor ecosystem. Overcoming the key challenges to integrating these advances into routine clinical practice will help unlock new treatment options for patients receiving cancer immunotherapy.","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"1 1","pages":""},"PeriodicalIF":46.9,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143831833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Mapping the patent landscape of TROP2-targeted biologics through deep learning","authors":"Yu Xiang, Yuyang Jin, Kunmeng Liu, Benzheng Wei","doi":"10.1038/s41587-025-02626-8","DOIUrl":"https://doi.org/10.1038/s41587-025-02626-8","url":null,"abstract":"There has been a rapid growth in patents related to TROP2, a transmembrane glycoprotein involved in calcium signal transduction and an attractive target for cancer therapy.","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"60 1","pages":""},"PeriodicalIF":46.9,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143831835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"FDA approves Alnylam’s anti-amyloid RNAi drug for cardiomyopathy","authors":"","doi":"10.1038/s41587-025-02656-2","DOIUrl":"https://doi.org/10.1038/s41587-025-02656-2","url":null,"abstract":"<p>The first RNA interference (RNAi) drug for treating heart failure caused by amyloidosis was approved by the US Food and Drug Administration (FDA) in March. Alnylam has the go-ahead for Amvuttra (vutrisiran) to treat transthyretin amyloid cardiomyopathy (ATTR-CM) caused by sporadic or hereditary ATTR, expanding the drug’s label from a previous nod in 2022 for polyneuropathy caused by transthyretin amyloidosis.</p><p>The disease ATTR-CM is rapidly progressive and fatal, and is caused by misfolding of the liver transport protein transthyretin. The abnormal protein fibrils are prone to aggregate and form damaging deposit in many organs, including the heart, leading to cardiovascular death, hospitalizations and urgent heart failure visits. Estimates suggest ATTR-CM affects over 300,000 people globally, but most cases are thought to be undiagnosed, and current treatments cannot halt its progression.</p>","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"42 1","pages":""},"PeriodicalIF":46.9,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143831850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yonatan Chemla, Itai Levin, Yueyang Fan, Anna A. Johnson, Connor W. Coley, Christopher A. Voigt
{"title":"Hyperspectral reporters for long-distance and wide-area detection of gene expression in living bacteria","authors":"Yonatan Chemla, Itai Levin, Yueyang Fan, Anna A. Johnson, Connor W. Coley, Christopher A. Voigt","doi":"10.1038/s41587-025-02622-y","DOIUrl":"https://doi.org/10.1038/s41587-025-02622-y","url":null,"abstract":"<p>Genetically encoded reporters are suitable for short-distance imaging in the laboratory but not for scanning wide outdoor areas from a distance. Here we introduce hyperspectral reporters (HSRs) designed for hyperspectral imaging cameras that are commonly mounted on unmanned aerial vehicles and satellites. HSR genes encode enzymes that produce a molecule with a unique absorption signature that can be reliably distinguished in hyperspectral images. Quantum mechanical simulations of 20,170 metabolites identified candidate HSRs, leading to the selection of biliverdin IXα and bacteriochlorophyll <i>a</i> for their distinct absorption spectra and biosynthetic feasibility. These genes were integrated into chemical sensor circuits in soil (<i>Pseudomonas putida</i>) and aquatic (<i>Rubrivivax gelatinosus</i>) bacteria. The bacteria were detectable outdoors under ambient light from up to 90 m in a single 4,000-m<sup>2</sup> hyperspectral image taken using fixed and unmanned aerial vehicle-mounted cameras. The dose–response functions of the chemical sensors were measured remotely. HSRs enable large-scale studies and applications in ecology, agriculture, environmental monitoring, forensics and defense.</p>","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"16 1","pages":""},"PeriodicalIF":46.9,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143819378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ayse G. Keskus, Asher Bryant, Tanveer Ahmad, Byunggil Yoo, Sergey Aganezov, Anton Goretsky, Ataberk Donmez, Lisa A. Lansdon, Isabel Rodriguez, Jimin Park, Yuelin Liu, Xiwen Cui, Joshua Gardner, Brandy McNulty, Samuel Sacco, Jyoti Shetty, Yongmei Zhao, Bao Tran, Giuseppe Narzisi, Adrienne Helland, Daniel E. Cook, Pi-Chuan Chang, Alexey Kolesnikov, Andrew Carroll, Erin K. Molloy, Chengpeng Bi, Adam Walter, Margaret Gibson, Irina Pushel, Erin Guest, Tomi Pastinen, Kishwar Shafin, Karen H. Miga, Salem Malikic, Chi-Ping Day, Nicolas Robine, Cenk Sahinalp, Michael Dean, Midhat S. Farooqi, Benedict Paten, Mikhail Kolmogorov
{"title":"Severus detects somatic structural variation and complex rearrangements in cancer genomes using long-read sequencing","authors":"Ayse G. Keskus, Asher Bryant, Tanveer Ahmad, Byunggil Yoo, Sergey Aganezov, Anton Goretsky, Ataberk Donmez, Lisa A. Lansdon, Isabel Rodriguez, Jimin Park, Yuelin Liu, Xiwen Cui, Joshua Gardner, Brandy McNulty, Samuel Sacco, Jyoti Shetty, Yongmei Zhao, Bao Tran, Giuseppe Narzisi, Adrienne Helland, Daniel E. Cook, Pi-Chuan Chang, Alexey Kolesnikov, Andrew Carroll, Erin K. Molloy, Chengpeng Bi, Adam Walter, Margaret Gibson, Irina Pushel, Erin Guest, Tomi Pastinen, Kishwar Shafin, Karen H. Miga, Salem Malikic, Chi-Ping Day, Nicolas Robine, Cenk Sahinalp, Michael Dean, Midhat S. Farooqi, Benedict Paten, Mikhail Kolmogorov","doi":"10.1038/s41587-025-02618-8","DOIUrl":"https://doi.org/10.1038/s41587-025-02618-8","url":null,"abstract":"<p>For the detection of somatic structural variation (SV) in cancer genomes, long-read sequencing is advantageous over short-read sequencing with respect to mappability and variant phasing. However, most current long-read SV detection methods are not developed for the analysis of tumor genomes characterized by complex rearrangements and heterogeneity. Here, we present Severus, a breakpoint graph-based algorithm for somatic SV calling from long-read cancer sequencing. Severus works with matching normal samples, supports unbalanced cancer karyotypes, can characterize complex multibreak SV patterns and produces haplotype-specific calls. On a comprehensive multitechnology cell line panel, Severus consistently outperforms other long-read and short-read methods in terms of SV detection F1 score (harmonic mean of the precision and recall). We also illustrate that compared to long-read methods, short-read sequencing systematically misses certain classes of somatic SVs, such as insertions or clustered rearrangements. We apply Severus to several clinical cases of pediatric leukemia/lymphoma, revealing clinically relevant cryptic rearrangements missed by standard genomic panels.</p>","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"183 1","pages":""},"PeriodicalIF":46.9,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143775369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Chenlei Hu, Mehdi Borji, Giovanni J. Marrero, Vipin Kumar, Jackson A. Weir, Sachin V. Kammula, Evan Z. Macosko, Fei Chen
{"title":"Scalable spatial transcriptomics through computational array reconstruction","authors":"Chenlei Hu, Mehdi Borji, Giovanni J. Marrero, Vipin Kumar, Jackson A. Weir, Sachin V. Kammula, Evan Z. Macosko, Fei Chen","doi":"10.1038/s41587-025-02612-0","DOIUrl":"https://doi.org/10.1038/s41587-025-02612-0","url":null,"abstract":"<p>Spatial transcriptomics enables gene expression mapping within tissues but is often limited by imaging constraints. We present an imaging-free approach that reconstructs spatial barcode locations using molecular diffusion and dimensionality reduction. Validated against ground truth imaging, our method achieves high fidelity and scales to centimeter-sized tissues. This approach enhances spatial transcriptomics’ accessibility and throughput, enabling large-scale studies without specialized imaging equipment.</p>","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"20 1","pages":""},"PeriodicalIF":46.9,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143766559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}